OTHARIS

Scribe Therapeutics Inc.

SCTX · Nasdaq · US

USD 15.54 +0.78% today

As of Nov 03, 2026 02:50 UTC — not a live feed

52-week range
USD 13.50 lowat 8% of its rangehigh 39.60
Market Cap
0.3B USD
Sector
Healthcare
Industry
Biotechnology

Scribe Therapeutics Inc. (SCTX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. At USD 15.54 it trades at 8% of its 52-week range (USD 13.50 – 39.60).

Otharis Plus · ProAnalysed from its filings when you open it

Is Scribe Therapeutics worth more than its price — and is its growth accelerating?

Two complete methods, run on SCTX's own numbers: Benjamin Graham's value test and the Otharis Growth Score. Every number is real and computed — never estimated.

Value Investing · Benjamin Graham7 criteria · value vs price · margin of safety
  • Size
  • Financial strength
  • Earnings stability
  • Dividend record
  • Earnings growth
  • Moderate P/E
  • Moderate price-to-book
Growth Investing · Otharis Growth Score7 criteria · speed · acceleration · margins
  • Revenue growth
  • Acceleration
  • EPS growth
  • Latest quarter
  • Margin expansion
  • Growth efficiency
  • Price momentum

The verdict, the values and every number behind them are inside Otharis.

✨

Otharis Research Free

A real, deterministic 22-section research report for SCTX - every line tagged FACT, MODEL OUTPUT, ASSUMPTION, ESTIMATE or RULE-BASED INTERPRETATION. 2 reports a day with a free account.

Unlock SCTX’s full analysis →

Start with a free account · Value & Growth analysis included in Otharis Plus and Pro